DOT1L and leukemia: EPZ004777 has been identified as a potent inhibitor of DOT1L and has been shown to inhibit leukemogenic gene expression, particularly in cells carrying Mixed Lineage Leukemia translocations, by blocking H3K79 methylation in in vivo studies [14].